Filed: 8/14/2025ACC: 0001848809-25-000005
๐ What this filing means
VELAN CAPITAL INVESTMENT MANAGEMENT LP filed this quarterly 13FโHR report disclosing 50 equity positions with a total reported market value of $101.24M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
50
Positions
$101.24M
Total AUM (reported)
24.31M
Total Shares
Allocation by class
COM$47.73M47.2%
COMNEW$36.51M36.1%
SPONSOREDADS$8.99M8.9%
COMSTK$6.48M6.4%
CALL$1.29M1.3%
SHS$97.5K0.1%
SHSEURO$91.8K0.1%
Portfolio Concentration
Top 3$31.41M31.0%
4โ10$38.77M38.3%
11โ25$28.06M27.7%
Rest$3.00M3.0%
Top 3 weight
31.0%
Top 10 weight
69.3%
Voting Authority Distribution
Total shares with voting rights: 24.31M
Sole
Full voting authority
23.49M
shares
% of voting shares96.6%
Shared
Joint voting authority
814.41K
shares
% of voting shares3.4%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole48
Shared0
Other2
Dominant voting typeSole ยท 96.6% of voting shares
Institutional Holdings50
Rows:
HERONTHERAPEUTICSINC
SOLEShares6.99M
TypeSH
Market value$14.46M
14.29%
Sole
6.99M
Shared
0.00
None
0.00
VERONAPHARMAPLC
SOLEShares95K
TypeSH
Market value$8.99M
8.88%
Sole
95K
Shared
0.00
None
0.00
JASPERTHERAPEUTICSINC
SOLEShares1.43M
TypeSH
Market value$7.96M
7.86%
Sole
1.19M
Shared
245.33K
None
0.00
PROTARATHERAPEUTICSINC
SOLEShares2.14M
TypeSH
Market value$6.48M
6.40%
Sole
2.14M
Shared
0.00
None
0.00
ZEVRATHERAPEUTICSINC
SOLEShares715K
TypeSH
Market value$6.30M
6.22%
Sole
715K
Shared
0.00
None
0.00
TOURMALINEBIOINC
OTRShares393.89K
TypeSH
Market value$6.30M
6.22%
Sole
74.81K
Shared
319.08K
None
0.00
PRAXISPRECISIONMEDICINESI
SOLEShares149.33K
TypeSH
Market value$6.28M
6.20%
Sole
149.33K
Shared
0.00
None
0.00
CIDARATHERAPEUTICSINC
SOLEShares100K
TypeSH
Market value$4.87M
4.81%
Sole
100K
Shared
0.00
None
0.00
ALUMISINC
SOLEShares1.62M
TypeSH
Market value$4.86M
4.80%
Sole
1.62M
Shared
0.00
None
0.00
ARVINASINC
SOLEShares500K
TypeSH
Market value$3.68M
3.64%
Sole
500K
Shared
0.00
None
0.00
SCPHARMACEUTICALSINC
SOLEShares917.67K
TypeSH
Market value$3.50M
3.45%
Sole
917.67K
Shared
0.00
None
0.00
REZOLUTEINC
SOLEShares750K
TypeSH
Market value$3.35M
3.30%
Sole
750K
Shared
0.00
None
0.00
LIQUIDIACORPORATION
SOLEShares239.26K
TypeSH
Market value$2.98M
2.94%
Sole
239.26K
Shared
0.00
None
0.00
MINERALYSTHERAPEUTICSINC
SOLEShares174.60K
TypeSH
Market value$2.36M
2.33%
Sole
174.60K
Shared
0.00
None
0.00
SUTROBIOPHARMAINC
SOLEShares3.06M
TypeSH
Market value$2.18M
2.16%
Sole
3.06M
Shared
0.00
None
0.00
INSPIREMDINC
SOLEShares904.03K
TypeSH
Market value$2.05M
2.03%
Sole
904.03K
Shared
0.00
None
0.00
PERSPECTIVETHERAPEUTICSINC
SOLEShares500K
TypeSH
Market value$1.72M
1.70%
Sole
500K
Shared
0.00
None
0.00
REPLIMUNEGROUPINC
SOLEShares183.08K
TypeSH
Market value$1.70M
1.68%
Sole
183.08K
Shared
0.00
None
0.00
TELABIOINC
SOLEShares747.41K
TypeSH
Market value$1.45M
1.43%
Sole
747.41K
Shared
0.00
None
0.00
EDESABIOTECHINC
OTRShares687.50K
TypeSH
Market value$1.40M
1.38%
Sole
437.50K
Shared
250K
None
0.00
NEKTARTHERAPEUTICS
SOLEShares50K
TypeSH
Market value$1.29M
1.28%
Sole
50K
Shared
0.00
None
0.00
VIRIDIANTHERAPEUTICSINC
SOLEShares86.50K
TypeSH
Market value$1.21M
1.19%
Sole
86.50K
Shared
0.00
None
0.00
UPSTREAMBIOINC
SOLEShares107K
TypeSH
Market value$1.17M
1.16%
Sole
107K
Shared
0.00
None
0.00
ELEDONPHARMACEUTICALSINC
SOLEShares338.97K
TypeSH
Market value$918.6K
0.91%
Sole
338.97K
Shared
0.00
None
0.00
AVALOTHERAPEUTICSINC
SOLEShares154.97K
TypeSH
Market value$773.3K
0.76%
Sole
154.97K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting โ Sole | Shared | None |
|---|---|---|---|---|---|---|---|
HERONTHERAPEUTICSINCSOLE | COM | 6.99M | SH | $14.46M 14.29% | 6.99M | 0.00 | 0.00 |
VERONAPHARMAPLCSOLE | SPONSOREDADS | 95K | SH | $8.99M 8.88% | 95K | 0.00 | 0.00 |
JASPERTHERAPEUTICSINCSOLE | COMNEW | 1.43M | SH | $7.96M 7.86% | 1.19M | 245.33K | 0.00 |
PROTARATHERAPEUTICSINCSOLE | COMSTK | 2.14M | SH | $6.48M 6.40% | 2.14M | 0.00 | 0.00 |
ZEVRATHERAPEUTICSINCSOLE | COMNEW | 715K | SH | $6.30M 6.22% | 715K | 0.00 | 0.00 |
TOURMALINEBIOINCOTR | COM | 393.89K | SH | $6.30M 6.22% | 74.81K | 319.08K | 0.00 |
PRAXISPRECISIONMEDICINESISOLE | COMNEW | 149.33K | SH | $6.28M 6.20% | 149.33K | 0.00 | 0.00 |
CIDARATHERAPEUTICSINCSOLE | COMNEW | 100K | SH | $4.87M 4.81% | 100K | 0.00 | 0.00 |
ALUMISINCSOLE | COM | 1.62M | SH | $4.86M 4.80% | 1.62M | 0.00 | 0.00 |
ARVINASINCSOLE | COM | 500K | SH | $3.68M 3.64% | 500K | 0.00 | 0.00 |
SCPHARMACEUTICALSINCSOLE | COM | 917.67K | SH | $3.50M 3.45% | 917.67K | 0.00 | 0.00 |
REZOLUTEINCSOLE | COMNEW | 750K | SH | $3.35M 3.30% | 750K | 0.00 | 0.00 |
LIQUIDIACORPORATIONSOLE | COMNEW | 239.26K | SH | $2.98M 2.94% | 239.26K | 0.00 | 0.00 |
MINERALYSTHERAPEUTICSINCSOLE | COM | 174.60K | SH | $2.36M 2.33% | 174.60K | 0.00 | 0.00 |
SUTROBIOPHARMAINCSOLE | COM | 3.06M | SH | $2.18M 2.16% | 3.06M | 0.00 | 0.00 |
INSPIREMDINCSOLE | COM | 904.03K | SH | $2.05M 2.03% | 904.03K | 0.00 | 0.00 |
PERSPECTIVETHERAPEUTICSINCSOLE | COMNEW | 500K | SH | $1.72M 1.70% | 500K | 0.00 | 0.00 |
REPLIMUNEGROUPINCSOLE | COM | 183.08K | SH | $1.70M 1.68% | 183.08K | 0.00 | 0.00 |
TELABIOINCSOLE | COM | 747.41K | SH | $1.45M 1.43% | 747.41K | 0.00 | 0.00 |
EDESABIOTECHINCOTR | COMNEW | 687.50K | SH | $1.40M 1.38% | 437.50K | 250K | 0.00 |
NEKTARTHERAPEUTICSSOLE | CALL | 50K | SH | $1.29M 1.28% | 50K | 0.00 | 0.00 |
VIRIDIANTHERAPEUTICSINCSOLE | COM | 86.50K | SH | $1.21M 1.19% | 86.50K | 0.00 | 0.00 |
UPSTREAMBIOINCSOLE | COM | 107K | SH | $1.17M 1.16% | 107K | 0.00 | 0.00 |
ELEDONPHARMACEUTICALSINCSOLE | COM | 338.97K | SH | $918.6K 0.91% | 338.97K | 0.00 | 0.00 |
AVALOTHERAPEUTICSINCSOLE | COMNEW | 154.97K | SH | $773.3K 0.76% | 154.97K | 0.00 | 0.00 |
Page 1 of 2